Hangzhou Converd Co., Ltd.
Clinical trials sponsored by Hangzhou Converd Co., Ltd., explained in plain language.
-
Virus and immune drug combo takes on advanced cancers
Disease control Recruiting nowThis study tests a new treatment for people with advanced solid tumors that have not responded to standard therapies. The treatment combines a modified virus (hV01) that targets and kills cancer cells while boosting the immune system, with an immunotherapy drug (tislelizumab) tha…
Phase: NA • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Virus injection fights advanced pancreatic cancer in new trial
Disease control Recruiting nowThis early-phase trial tests a modified virus (hV01) that is injected directly into tumors to fight advanced pancreatic cancer. The study will enroll 12 adults whose cancer has not responded to standard treatments. The main goal is to see if the virus can shrink tumors and contro…
Phase: PHASE2 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC